visine 0.5 mg/ml silmätipat
pfizer service company bvba - tetryzolini hydrochloridum - silmätipat - 0.5 mg/ml - tetrytsoliini
prilium 75 mg jauhe oraaliliuosta varten
vetoquinol s.a. - imidapril hydrochloride - jauhe oraaliliuosta varten - 75 mg - imidapriili
prilium 150 mg jauhe oraaliliuosta varten
vetoquinol s.a. - imidapril hydrochloride - jauhe oraaliliuosta varten - 150 mg - imidapriili
prilium 300 mg jauhe oraaliliuosta varten
vetoquinol s.a. - imidapril hydrochloride - jauhe oraaliliuosta varten - 300 mg - imidapriili
adrenalin aguettant 0.1 mg/ml injektioneste, liuos, esitäytetty ruisku
laboratoire aguettant - adrenaline tartrate - injektioneste, liuos, esitäytetty ruisku - 0.1 mg/ml - adrenaliini
adrenalin aguettant 1 mg/ml injektioneste, liuos, esitäytetty ruisku
laboratoire aguettant - adrenaline tartrate - injektioneste, liuos, esitäytetty ruisku - 1 mg/ml - adrenaliini
coxevac
ceva santé animale - inaktivoitu coxiella burnetii -rokote, nine mile -kanta - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.
visclear 0.5 mg/ml silmätipat, liuos
mcneil, a division of janssen- cilag oy - tetryzolini hydrochloridum - silmätipat, liuos - 0.5 mg/ml - tetrytsoliini
doxorubicin accord 2 mg/ml infuusiokonsentraatti, liuosta varten
accord healthcare b.v. - doxorubicin hydrochloride - infuusiokonsentraatti, liuosta varten - 2 mg/ml - doksorubisiini
voriconazole aristo 200 mg infuusiokuiva-aine, liuosta varten
aristo pharma gmbh - voriconazolum - infuusiokuiva-aine, liuosta varten - 200 mg - vorikonatsoli